Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis

Rev Esp Cardiol (Engl Ed). 2021 May;74(5):427-435. doi: 10.1016/j.rec.2020.03.005. Epub 2020 May 19.
[Article in English, Spanish]

Abstract

Introduction and objectives: Neoatherosclerosis is one of the causes of in-stent restenosis (ISR). Our objective was to evaluate the influence of neoatherosclerosis on prognosis and treatment response in patients with ISR.

Methods: This is a pooled analysis of the optical coherence tomography (OCT)-substudies of 2 multicenter, randomized clinical trials, RIBS IV and V, comparing treatment with paclitaxel-coated balloon vs everolimus-eluting stent in patients with ISR. OCT evaluation was performed at baseline and at 6 to 9 months. Neoatherosclerosis was defined in baseline OCT as neointima with calcified or lipid content. We evaluated the angiographic and OCT results at 6 to 9 months and the occurrence of major adverse cardiovascular events at 3 years of follow-up in patients with and without neoatherosclerosis treated with paclitaxel-coated balloon or everolimus-eluting stents.

Results: Sixty-four patients underwent OCT at the time of the index procedure. Neoatherosclerosis was documented in 23 (36%) lesions. Angiographic follow-up at 6 to 9 months showed no differences in restenosis [5 (24%) vs 6 (15%) P=.49], minimum lumen diameter (1.79±0.7 vs 1.94±0.6mm; P=.41) or late loss (0.33±0.7 vs 0.15±0.5; P=.34) in patients with and without neoatherosclerosis, respectively. Follow-up OCT confirmed the absence of differences in quantitative parameters and the characteristics of tissue coverage between the 2 groups. At 3 years of follow-up, the major adverse cardiovascular events rate was 3 (13%) vs 5 (12%) in the neoatherosclerosis and nonneoatherosclerosis groups (HR, 0.94; 95%CI, 0.22-3.93; P=.93).

Conclusions: In this limited study population, OCT-defined neoatherosclerosis did not seem to influence acute and long-term outcomes in patients randomized to paclitaxel-coated balloon or everolimus-eluting stents for ISR.

Keywords: Neoaterosclerosis; Neoatherosclerosis; Optical coherence tomography; Reestenosis; Restenosis; Tomografía de coherencia óptica.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Coronary Angiography
  • Coronary Restenosis* / diagnosis
  • Drug-Eluting Stents*
  • Humans
  • Paclitaxel
  • Prognosis
  • Tomography, Optical Coherence
  • Treatment Outcome

Substances

  • Paclitaxel